XERS
Xeris Biopharma Holdings Inc

10,702
Mkt Cap
$967.34M
Volume
1.36M
52W High
$10.08
52W Low
$3.81
PE Ratio
-748.00
XERS Fundamentals
Price
$5.29
Prev Close
$5.61
Open
$5.53
50D MA
$6.70
Beta
1.30
Avg. Volume
1.81M
EPS (Annual)
$0.0032
P/B
68.12
Rev/Employee
$670,908.05
$1,503.09
Loading...
Loading...
News
all
press releases
350,168 Shares in Xeris Biopharma Holdings, Inc. $XERS Purchased by Granahan Investment Management LLC
Granahan Investment Management LLC purchased a new stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) during the third quarter, according to its most recent disclosure with the SEC...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Divisadero Street Capital Management LP Takes $3.31 Million Position in Xeris Biopharma Holdings, Inc. $XERS
Divisadero Street Capital Management LP bought a new stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) in the 3rd quarter, according to the company in its most recent filing with...
MarketBeat·8d ago
News Placeholder
Xeris Biopharma Holdings, Inc. $XERS Shares Sold by Rosalind Advisors Inc.
Rosalind Advisors Inc. reduced its position in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Free Report) by 16.7% in the 3rd quarter, according to its most recent filing with the...
MarketBeat·11d ago
News Placeholder
Xeris Biopharma (NASDAQ:XERS) Upgraded by Wall Street Zen to Strong-Buy Rating
Wall Street Zen raised Xeris Biopharma from a "buy" rating to a "strong-buy" rating in a report on Saturday...
MarketBeat·17d ago
News Placeholder
Beth Hecht Sells 16,667 Shares of Xeris Biopharma (NASDAQ:XERS) Stock
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the business's stock in a transaction on Monday, March 2nd. The shares were sold at an average...
MarketBeat·19d ago
News Placeholder
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) has been assigned an average rating of "Moderate Buy" from the eight ratings firms that are presently covering the stock, MarketBeat...
MarketBeat·20d ago
News Placeholder
Xeris Biopharma (NASDAQ:XERS) Insider Sells $104,168.75 in Stock
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS - Get Free Report) insider Beth Hecht sold 16,667 shares of the firm's stock in a transaction on Monday, March 2nd. The shares were sold at an average...
MarketBeat·20d ago
News Placeholder
Xeris Biopharma (NASDAQ:XERS) Issues Earnings Results
Xeris Biopharma (NASDAQ:XERS - Get Free Report) announced its quarterly earnings results on Monday. The company reported $0.06 earnings per share for the quarter, beating analysts' consensus...
MarketBeat·22d ago
News Placeholder
Xeris Biopharma (NASDAQ:XERS) Receives Buy Rating from HC Wainwright
HC Wainwright restated a "buy" rating and set a $10.00 price objective on shares of Xeris Biopharma in a research report on Monday...
MarketBeat·22d ago
News Placeholder
Xeris Biopharma (NASDAQ:XERS) Shares Gap Up - Here's What Happened
Xeris Biopharma (NASDAQ:XERS) Shares Gap Up - What's Next...
MarketBeat·22d ago
<
1
2
...
>

Latest XERS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.